iifl-logo

Docmode Health Technologies Ltd Directors Report

68.15
(4.93%)
Sep 26, 2025|12:00:00 AM

Docmode Health Technologies Ltd Share Price directors Report

To,

The Members,

Your Directors take pleasure in presenting 8th (Eighth) Annual Report of your Company together with the Audited Financial Statement for the year ended 31st March, 2025.

1. Financial Performance of the Company:

Particulars Standalone Consolidated
2024-25 2023-24 2024-25 2023-24
Income 4270.27 4014.33 4270.28 4,014.33
Expenditure 4467.29 3,979.75 4466.79 3,980.36
Profit/ (Loss) Before Tax (197.02) 34.58 (196.52) 33.97
Less: Tax expense - 20 - 20
Less: Deferred tax (6.80) (4.28) (6.79) (4.28)
Less: Tax in respect of earlier years 12.92 (0.51) 12.92 (0.51)
Profit/ (Loss) after tax (203.14) 19.37 (202.64) 18.76
Less: Preference Dividend - - - -
Add: Previous Year Balance B/F 724.19 118.60 723.20 118.21
Less: Capitalization of reserves - - - -
Balance carried to Balance Sheet 521.05 724.19 520.53 723.20
Less: Equity Dividend - - - -

2. Details of the Subsidiaries, Associate and Joint Ventures:

The Company does not have any Joint Venture or Associate Company as on 31st March, 2025. The statement containing salient features of the financial statements of the Companys subsidiary is given in Form AOC-1 as an Annexure-I to this Directors Report.

The highlights of performance of subsidiaries and their contribution to the overall performance of the Company during the financial year is given under the consolidated financial statements forming part of the Annual Report.

During the year under review, none of the companies ceased to be a subsidiary of the Company.

3. State of the Companys Affairs:

The Company has earned total income of Rs. 4270.27 Lakhs [Previous Year: Rs. 4014.33 Lakhs on a standalone basis and INR 4270.28 Lakhs [Previous Year: INR 4,014.33 Lakhs] on consolidated basis. The expenses incurred during the year are INR 4467.29 Lakhs [Previous Year: INR 3,979.75 Lakhs] on standalone basis and INR 4466.79 Lakhs [Previous Year: INR 3,980.36 Lakhs] on consolidated basis. After meeting all the expenses, your Company has incurred a total loss after tax of INR 203.14 Lakhs [Previous Year: 19.37 Lakhs] on standalone basis and INR 202.64 Lakhs [Previous Year: 18.76 Lakhs] on consolidated basis.

Your Directors are expecting better business opportunities in the coming year, which may lead to expansion and diversification of the business of the company.

4. Transfer to Reserve:

During the Financial Year 2024-25, the Company has not transferred any amount to the general reserve.

5. Change in the Nature of Business, if any:

There is no change in nature of business. However, during the year, the Company has altered its Main Object and have added objects related to healthcare, chemicals, research etc. and accordingly have altered its Main Object vide Members resolution passed in Annual General Meeting held on 30th September 2024.

6. Allotment and listing of shares:

During the financial year, the Company has not allotted any shares nor listed any shares on stock exchange.

7. Material Changes and Commitments, if any:

The Company has received a notice from the Debenture Trustee dated 30th June, 2025 and 22nd August, 2025, acting on the instructions of the Debenture Holders Ms. Bindi Mehta and Ms. Varsha Mehta, for enforcement of part of the pledged security on account of continuing default. In accordance with the provisions of the Share Pledge Agreements dated 7th May, 2024 and 24th May, 2024, read with the Debenture Transfer and Composite Amendment Agreement dated 17th December, 2024, 7,57,923 equity shares equally held by both the promoters, Mr. Paulson Paul Thazhathedath and Mr. Hans Lewis, constituting 24.12% of the total paid-up capital of the Company and pledged in favour of the Debenture Trustee, out of which pledge has been invoked on 5,21,063 equity shares, as per the instructions of the one of the NCD holders, Ms. Bindi Mehta.

8. Change in Registered Office of the Company:

During the Financial Year, the registered office of the company was shifted from 201, Kalpataru Plaza, Rambaug Off Chincholi Bunder Road, Malad West, Mumbai – 400064, Maharashtra, India to 307, Shivai Plaza, Marol Cooperative Industrial Estate Road, Sagbag, Marol, Andheri East, Mumbai – 400059, Maharashtra, India, within local limits of city or town.

9. Dividend:

Your Directors, during the Financial Year under review have not recommended any dividend on the Equity Shares of the Company.

10. Transfer of unclaimed shares/dividend and interest thereon to IEPF:

As required under Section 124 of the Act there are no unclaimed shares /dividend and interest thereon lying with the Company for a period of seven years liable to be transferred to the Investor Education and Protection Fund (IEPF) established by the Central Government.

11. Details of Adequacy of Internal Financial Controls:

Your Company has put in place adequate Internal Financial Controls commensurate to the scale of operations.

12. Disclosure of Accounting Treatment:

These Financial statements of the Company are prepared in accordance with the Applicable Accounting Standards ("AS"), notified under section 133 of Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India of the net profit and other comprehensive income and other financial information.

13. Details of Significant and Material Orders Passed by the Regulators or Courts or Tribunals

Impacting the Going Concern Status and Companys Operations in Future, if any:

No Material Orders were passed by the Regulators or Courts or Tribunals impacting the going concern status and Companys operations in the future.

14. Significant Changes:

a. The Company has transferred 5% stake held in CCME to Mr. Amarjeet Thakur w.e.f 1st April, 2024, thereby CCME ceased to be wholly own subsidiary of Docmode Health Technologies Limited and has become subsidiary of the company.

b. The Company has issued and allotted 85 Senior, Unrated, Unlisted, Secured, Redeemable Non-Convertible Debentures (NCDs Tranche-I) to Aquilon Capital Emerging Sectors I and 15 NCDs to Capier Investments One, which was approved in Extra-Ordinary General Meeting dated 22nd April, 2024, against which both the Promoters i.e., Paulson Thazhathedath and Mr. Hans Lewis have pledged 1,12,500 equity shares each from their respective shareholding as collateral for the issuance of NCDs on 9th May, 2024. Additionally, charge has also been created to secure the repayment of said NCDs, as per the agreements entered by the company with the NCDs holders.

c. The Company has issued and allotted 125 Senior, Unrated, Unlisted, Secured, Redeemable Non-Convertible Debentures (NCDs Trench-II) to Aquilon Capital Emerging Sectors I, which was approved in Extra-Ordinary General Meeting dated 22nd April, 2024, against which both the Promoters Paulson Thazhathedath and Mr. Hans Lewis have pledged 82,500 equity shares each from respective shareholding as collateral for the issuance of NCDs on 28th May, 2024. Additionally, charge has also been created to secure the repayment of NCDs, as per the agreements entered by the company with the NCDs holders.

d. Subsequently, to meet the minimum requirement of share pledge based on market capitalization, an additional 260,967 equity shares (Tranche-I and Tranche -II) each from the respective holdings of both Promoters have been pledged as collateral for the issuance of above mentioned NCDs on 2nd August, 2024. Accordingly, charge has also been modified to secure the repayment of said NCDs, as per the agreements entered by the company with the NCDs holders.

e. Mr. Paresh Jaysih Sampat was appointed as Managing Director of the Company with effect from 30th September, 2024 in the Annual General Meeting.

f. The Company had altered its Main Object vide members resolution passed in Annual General Meeting held on 30th September, 2024.

g. During the financial year, Capier Investments One, one of the NCD holders, holding 15 NCDs of

Tranche-I, transferred these NCDs to Aquilon Capital Emerging Sectors I on 12th November 2024. h. During the financial year, there was a significant change in the holding pattern of the Companys Non-Convertible Debentures. Aquilon Capital Emerging Sectors I, which previously held a total of 225 Senior, Unlisted, Unrated, Secured, Redeemable Non-Convertible Debentures (comprising 100 NCDs under Tranche I and 125 NCDs under Tranche II, each having a face value of 1,00,000), transferred an aggregate of 150 NCDs. The transfer comprised 100 NCDs under Tranche I and 50 NCDs under Tranche II. Out of this, 25 NCDs were transferred to Ms. Bindi Mehta and another 25 NCDs to Ms. Varsha Mehta. The said transfer was duly approved by the Board of Directors at its meeting held on 11th December, 2024.

15. Number of Meeting of Board of Directors held during the year:

The Board of Directors duly met 10 (Ten) times, during the year on 10/05/2024, 27/05/2024, 30/05/2024, 22/07/2024, 08/08/2024, 27/08/2024, 09/10/2024, 14/11/2024, 11/12/2024 and 12/03/2025 in respect of which proper notices were given and the proceedings were properly recorded, signed and maintained in the Minutes book kept by the Company for the purpose.

16. Meetings of the Members:

The Last i.e. the 07th Annual General Meeting of the Company for the financial year 2023-2024 was held on 30/09/2024 at the Registered Office of the Company.

17. Particulars of the Extra-Ordinary General Meeting of the Company held during the year

An Extra Ordinary General Meeting of the members was held on 22nd April, 2024, at the registered office of the company.

18. Directors and Key Managerial Personnel:

Appointments / Re-appointments / Changes in designation:

Mr. Paresh Jaysih Sampat (DIN: 00410185), who was appointed as an Additional Director with effect from 08th August, 2024, was regularised as Director pursuant to an Ordinary Resolution passed by the shareholders at the Annual General Meeting held on 30th September, 2024

Mr. Paresh Jaysih Sampat (DIN: 00410185) was appointed as the Managing Director of the Company with effect from 30th September, 2024, pursuant to the Special Resolution passed by the shareholders at the Annual General Meeting held on the same date.

Mr. Paulson Paul Thazhathedath (DIN: 02301881) was re-designated as Whole-Time Director from the position of Managing Director with effect from 30th September, 2024, pursuant to the Special Resolution passed by the shareholders at the Annual General Meeting held on that date.

Resignations:

Mr. Krushang Rajenkumar Shah (DIN: 10048419), Independent Director, and Ms. Hiral Rushang Gandhi (DIN: 10092573), Non-Executive Director, resigned from the Board of the Company with effect from 24th April, 2024.

Ms. Reshma Susan Thomas, Company Secretary of the Company, resigned from her position with effect from 30th April, 2025.

Directors liable to retire by rotation:

During the year under review, Mr. Paulson Paul Thazhathedath, Whole-time Director, is liable to retire by rotation at the ensuing Annual General Meeting of the Company pursuant to the provisions of Section 152 of the Companies Act, 2013 read with the Companies (Appointment and Qualification of Directors) Rules, 2014 and the Articles of Association of the Company. Being eligible, he has offered himself for re-appointment, based on the recommendation of the Nomination and Remuneration Committee and the approval of the Board of Directors."

Key Managerial Personnel:

As on 31st March, 2025, the following are the Key Managerial Personnel of the Company in terms of Section 203 of the Companies Act, 2013 read with the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014: Mr. Paresh Jaysih Sampat, Managing Director; Mr. Hans Albert Lewis, Chief Financial Officer; Mr. Paulson Paul Thazhathedath, Whole-time Director and Ms. Reshma Susan Thomas, Company Secretary & Compliance Officer."

Independent Directors:

The Independent Directors of the Company hold office for a term of five (5) years and are not liable to retire by rotation in terms of the provisions of the Companies Act, 2013. The present Independent Directors of the Company are Mr. Nilay Shivnarayan Sharma and Mr. Sujit Nityanand Chakraborty.

Declaration of Independence from Independent Directors:

The Company has received declarations from all the Independent Directors confirming that they meet the criteria of independence as prescribed under the provisions of the Act, read with the schedules and rules issued thereunder.

Apart from the above-mentioned changes, during the Financial Year under review, no other changes took place in the constitution of the Board of Directors of the Company:

As on 31st March, 2025, the Board of Directors of the Company comprised the following: Mr. Paulson Paul Thazhathedath, Mr. Hans Albert Lewis, Mr. Nilay Shivnarayan Sharma, Mr. Sujit Nityanand Chakraborty, Mr. Paresh Jaysih Sampat and Ms. Monina Elizabeth Lewis.

19. Committees of the Board:

Audit Committee:

Audit Committee of the Board is duly constituted in accordance with the provisions of Section 177 (8) of the Act read with Rule 6 of the Companies (Meetings of the Board and its Powers) Rules, 2014 and Regulation 18 of the Listing Regulations. The details of its composition & meetings held during the Financial Year 2024-25 etc., is as below. All recommendations made by the Audit Committee were accepted by the Board during the Financial Year 2024-25. During the year under review there are Eight (8) audit committee meetings held.

As on 31st March, 2025, the Audit Committee comprised of Mr. Sujit Nityanand Chakraborty as Chairman, Non-Executive Independent Director, Mr. Nilay Shivnarayan Sharma as Member, Non-Executive Independent Director and Ms. Monina Elizabeth Lewis as Member, Non-Executive Director.

Nomination and Remuneration Committee:

The Board of Directors has formulated a policy that provides a framework for the selection and appointment of Directors and Senior Management, and for determining the qualifications, positive attributes, and independence of Directors. The Board has also adopted a policy relating to the remuneration of Directors, Key Managerial Personnel, and Senior Management, which is available on the Companys website at https://docmode.org/policy/. During the year under review, five (5) meetings of the Nomination and Remuneration Committee were held.

Stakeholders Relationships Committee:

The Company has formulated and adopted Stakeholders Relationships Committee in accordance with the provisions of the Companies Act, 2013 read with the Rules made thereunder and the Listing Regulations. During the year under review Five (5) Stakeholders Relationship committee meetings was held. The details of its composition during the Financial Year 2024-25 etc., is as below.

As on 31st March, 2025, the Stakeholders Relationships Committee comprised of Mr. Sujit Nityanand Chakraborty as Chairman, Non-Executive Independent Director, Mr. Nilay Shivnarayan Sharma as Member, Non-Executive Independent Director and Ms. Monina Elizabeth Lewis as Member, Non-Executive Director.

Details of Investor Complaints

Complaints at the beginning of FY 2024-25 0
Complaints received during the year 0
Complaints resolved during the year 0
Complaints unresolved during the year 0
Complaints pending during the year 0
Complaints at the end of FY 2024-25 0

20. Independent Directors:

As on 31st March, 2025, the Board of Directors of the Company included 2 (Two) Independent Directors Mr. Sujit Nityanand Chakraborty and Mr. Nilay Shivnarayan Sharma. In Compliance with the Companies Act, 2013 and SEBI (Listing Obligations and Regulations) Requirement, 2015; the Independent Directors Meeting of the Company was held on 26th March, 2025.

Independent Directors of the Company have been issued formal letters of appointment setting out in detail the terms of their appointment, roles, duties and responsibilities. The Company also conducts familiarization programs from time to time to keep the Independent Directors updated on their roles, rights, responsibilities, the nature of the industry in which the Company operates, and the business model of the Company.

Web link of Website for the Familiarization Policy for Independent Directors: https://d3030h7whein66.cloudfront.net/PDF/DocMode+/7.+Directors+Familiarisation+Programe_Doc mode.pdf.

21. Annual Evaluation of Boards and Committee Performance:

Pursuant to the provisions of the Act, the SEBI LODR Regulations and the Guidance Note issued by SEBI, the Nomination and Remuneration Committee of the Board carried out an evaluation of performance of Independent Director, Individual Executive and Non-Executive Director and Board as whole and that of its committees.

The performance evaluation of the Chairman, the Non-Independent Directors and the Board as a whole was carried out by the Independent Directors in a separate meeting held on 26th March, 2025 after considering their overall contribution and engagement in the growth of the Company, active role in monitoring the effectiveness of Companys Corporate Governance practices and adherence to the Code of Conduct etc. The exercise of performance evaluation was carried out through a structured evaluation process covering various criteria as recommended by the Nomination and Remuneration Committee.

The Board of Directors evaluated the performance of the Nomination and Remuneration Committee based on the Committees terms of reference. Additionally, the Committee undertook a review of the Board and other Committees. The responsibility for evaluating the Nomination and Remuneration Committee itself was placed with the Board of Directors.

Overall, the performance of the Independent Director, Individual Executive and Non-Executive Director and the Board as whole and that of its committees as a whole was quite satisfactory and up to the mark during the year under review.

22. Whistle Blower Policy:

Pursuant to the provisions of Section 177(9) of the Act, the Board of Directors of the Company has framed the Vigil Mechanism/ Whistle Blower Policy for employees and/ or volunteers of the Company. The said Policy encourages to report any action or suspected action taken within the Company that is illegal, fraudulent or in violation of any adopted policy of the Company including reporting of instances of leak or suspected leak of unpublished price sensitive information. The Policy also provides access to the Chairperson of the Audit Committee under certain circumstances. The Whistle Blower Policy is posted on the website of the Company at https://d3030h7whein66.cloudfront.net/PDF/DocMode+/1.+Whistle+Blower+Policy_Docmode.pdf.

23. Directors Responsibility Statement:

To the best of their knowledge and belief and according to the information and explanations obtained by them, your Directors make the following statement in terms of the Provisions of the Section 134 (5) of the Companies Act, 2013 (the Act):

a. That in the preparation of the Annual Accounts for the year ended 31st March, 2025, the applicable accounting standards have been followed along with proper explanation relating to material departures, if any;

b. That the Directors have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company as at 31st March, 2025 and of the profit of the Company for the year ended on that date;

c. That the Directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

d. The Annual Accounts have been prepared on a going concern basis; and

e. The Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

24. Management Discussion and Analysis:

The Management Discussion and Analysis report as required under Regulation 34 and Schedule V of SEBI (Listing Obligations and Discloser Requirements) Regulations, 2015 forms and integral part of this report and provides overview of the business and operations of the Company as per Annexure-II

25. Code of Conduct:

The Board of Directors has adopted the Policy on Codes of Fair Disclosure and Conduct ("Fair Disclosure Code") in accordance with the requirements of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The Fair Disclosure Code of the Company lays down guidelines and procedures to be followed and disclosures to be made while dealing with shares of the Company as well as consequences of violation.

The code of practices and procedures for fair Disclosures of unpublished price sensitive information and code of conduct to regulate, monitor and report trading by Insiders is available on the website https://d3030h7whein66.cloudfront.net/PDF/DocMode+/5.+Policy+on+Code+of+Fair+Disclosure+of +UPSI_Docmode.pdf.

All Board members and Senior Management Personnel have affirmed compliance of the Code of Conduct. The Board has also adopted separate code of conduct with respect to duties of Independent Directors as per the provisions of the Companies Act, 2013 and is available on the website https://d3030h7whein66.cloudfront.net/PDF/DocMode+/11.+Policy+on+code+of+conduct+for+Indep endent+Directors_Docmode.pdf.

26. Auditors:

In line with the Resolution passed in the Annual General Meeting of the Company held in the Calendar Year 2023, M/s. R. Sundaresan Aiyar & Co., Chartered Accountants, Mumbai (ICAI Firm Registration Number: 110564W/ Membership No. 043946) were appointed as Statutory Auditors of the Company for a period of 5 years till the conclusion of Annual General Meeting of the Company to be held in the calendar year 2028.

27. Audit Report:

27.1 (i) For the year under review the audit report of the Company contains adverse mark or qualification by the Statutory Auditors of the Company regarding default made in repayment of loans and borrowings and in payment of interest thereon. (ii) Further, Tax Deducted at Source (TDS) of Rs. 54.66 lakhs were not deposited with the Income Tax Department as of 31st March, 2025, and it has been pending for more than 6 months. (iii) The Company has incurred cash loss of Rs. 167 Lakhs in the financial year.

27.2 Comments of Directors on Audit Report:

With respect to the observations made by the Statutory Auditors in their report regarding the default in repayment of principal and interest on Non-Convertible Debentures (NCDs), the Board of Directors wishes to state that the Company has been facing temporary liquidity constraints arising from a slowdown in collections, increased working capital requirements, and timing mismatches in operational cash flows. These factors have resulted in delays in servicing debt obligations. Consequently, a pledge on 7,57,923 equity shares, constituting 24.12% of the total paid-up share capital of the Company and equally held by the promoters, was invoked in favour of the Debenture Trustee as per the instructions of one of the NCD holders, Ms. Bindi Mehta. The Board, along with the promoters, is actively engaged in discussions and exploring restructuring measures to regularize these obligations and safeguard the interests of all stakeholders.

Further, the Auditors have also observed that Tax Deducted at Source (TDS) amounting to Rs. 54.66 lakhs remained unpaid for more than six months as at 31st March, 2025, and that the Company has incurred a cash loss of Rs. 167 lakhs during the financial year. These matters are also a consequence of the liquidity pressures explained above. The Company has initiated steps to clear the pending TDS liability in a phased manner along with applicable interest and is committed to ensuring strict compliance with all statutory obligations in future. Simultaneously, the management, together with the promoters, is pursuing cost optimization, operational efficiency initiatives, and exploring additional funding support to strengthen the financial position. The Board is confident that these corrective measures will enable the Company to regularize its statutory and debt obligations and restore financial stability for the benefit of all stakeholders.

28. Details of remuneration as required under Section 197(12) of the Companies Act, 2013:

The percentage increase in remuneration of each Director, Chief Financial Officer and Company Secretary during the financial year 2024-25, ratio of the remuneration of each Director to the median remuneration of the employees of the Company for the Financial Year 2024-25 and the comparison of remuneration of each Key Managerial Personnel (KMP) are given in Annexure-III.

29. Particulars Of Employees:

Particulars of the employees as required to be disclosed in terms of Section 134 of the Companies Act, 2013 read with Rule 5 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 are given in Annexure-IV.

28. Secretarial Auditor:

28 Pursuant to the provisions of Section 204 of the Act read with the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, the Board of Directors had appointed M/s. Vidhi Jobanputra & Co., Practicing Company Secretary (FCS No.: 11160 : C. P. No.: 22293) to conduct the Secretarial Audit of the Company for financial year 2024-25. The Secretarial Audit Report is annexed to this Report as Annexure-V. The said Report contains following qualifications / reservations or adverse remarks:

28.1 Regulation 242 of the SEBI (ICDR) Regulations, 2018 provides that locked-in securities held by promoters may be pledged as collateral only in favour of a scheduled commercial bank, a public financial institution, a systemically important NBFC, or a housing finance company for securing loans. However, for the purpose of securing 225 Non-Convertible Debentures (NCDs) issued to the NCDs holders as mentioned in this Directors Report, the shares were pledged in favour of Orbis Trusteeship Services Private Limited, the Debenture Trustee company.

28.2 The Company had approved the Financial Results and the Limited Review Report for the half-year ended 30th September, 2024, at its meeting held on 14th November, 2024. As per regulatory requirements, the outcome of the meeting along with the financial results was required to be submitted within 30 minutes of the conclusion of the meeting. However, the outcome was submitted on 16th November, 2024, and the financial results were submitted on 14th February, 2025. The delay occurred due to the expiry of the Statutory Auditors peer review certificate, which required additional time for renewal. The Company had intimated NSE about the situation in a timely manner.

28.3 The Company Secretary and Compliance Officer of the Company resigned with effect from 30th April, 2025. In terms of Regulation 6 of the SEBI (LODR) Regulations, 2015, a listed entity is required to appoint a qualified Company Secretary as Compliance Officer, and such appointment is to be made within three months from the date of vacancy. Accordingly, the due date for appointment of the new Company Secretary and Compliance Officer was 31st July, 2025. However, the appointment has not been made till date. In the interim, Mr. Paulson Paul Thazhathedath has been designated to respond to queries raised by NSE, stakeholders, and other regulatory authorities.

28.4 The Company has received a notice from the Debenture Trustee dated 30th June, 2025 and 22nd August, 2025, acting on the instructions of the Debenture Holder, Ms. Bindi Mehta and Ms. Varsha Mehta, for enforcement of part of the pledged security on account of continuing default on repayment of principal and interest on Rs. 1,50,00,000/- (Tranche-I and Tranche-II NCDs) raised from Ms. Bindi Mehta and Ms. Varsha Mehta by the Company. Consequently, 7,57,923 equity shares, equally held by the promoters, Mr. Paulson Paul Thazhathedath and Mr. Hans Lewis, and constituting 24.12% of the total paid-up share capital of the Company, out of which pledge has been invoked on 5,21,063 equity shares, as per the instructions of the one of the NCD holders, Ms. Bindi Mehta.

28.5 The Company made a delay of one (1) day in submitting the prior intimation under Regulation 29(2)/29(3) of SEBI (LODR) Regulations, 2015, in respect of the Board Meeting convened to consider the audited financial results for the half-year ended 31st May, 2025.

Comments of Directors on Secretarial Audit Report:

a. Observation 28.1: The Board notes the deviation from the regulatory requirement and clarifies that the pledge was created solely to secure borrowings raised through NCDs in the best interest of the Company. The matter is being reviewed, and necessary corrective actions will be taken to ensure future compliance.

b. Observation 28.2: The Board acknowledges the delay and regrets the non-compliance. It is clarified that the delay was procedural in nature and not intentional. The Company has strengthened its internal monitoring mechanism to avoid recurrence and will ensure timely submission of financial results in the future.

c. Observation 28.3: The Board recognizes the importance of appointing a qualified Compliance Officer and confirms that continuous efforts are being made to identify and appoint a suitable candidate at the earliest. Necessary newspaper advertisements have been issued and discussions have been held with HR agencies; however, the Company has not yet been able to finalize an appropriate candidate. In the meantime, interim arrangements have been made to ensure regulatory and stakeholder communications are not disrupted.

d. Observation 28.4: The Board regrets the financial stress that has resulted in defaults under the NCD obligations. The Board assures stakeholders that every effort is being made to protect the interests of shareholders and creditors.

e. Observation 28.5: The Board acknowledges the lapse, which occurred due to issues faced while uploading the intimation on the stock exchange portal. Steps are being taken to strengthen compliance monitoring processes to ensure strict adherence to prescribed timelines in future.

29 Compliance with the Secretarial Standards:

The Company has complied with all the necessary provisions of "Secretarial Standards on Meetings of the Board of Directors" and "Secretarial Standards on General Meetings" issued by the Institute of Company Secretaries of Indian, from time to time.

30 Extract of Annual Return:

As required, in accordance with the Section 92(3) of the Act, copy of Annual Return in Form MGT-7, is available on the website of the Company www.docmode.com

31 Conservation of Energy, Technology Absorption and Foreign Exchange Earnings & Outgo:

Information in accordance with the provisions of 134(3)(m) of the Act read with the Companies (Accounts) Rules, 2014, regarding conservation of energy, technology absorption, Foreign Exchange Earnings and Outgo is given in below:

a. Conservation of Energy:

i. the steps taken or impact on conservation of energy: Energy consumption is monitored and maintenance systems are improved.

ii. the steps taken by the Company for utilizing alternate sources of energy: The Company is trying to make effective/ efficient use of current sources of energy.

iii. the capital investment on energy conservation equipments: NIL

b. Technology Absorption and Research & Development: The Companys operations do not require significant import of technology. No expenditure had been incurred on research & development activities.

c. Foreign Exchange Earning and Outgo:

No. Particulars 2024-25 2023-24
1. Earning in Foreign Exchange 6.89 10.45
2. Outgo in Foreign Exchange 99.66 29.80

32 Details relating to Deposits:

The Company has not accepted any deposits from the public/members under Section 73 of the Companies Act, 2013 (hereinafter referred to as the Act) read with Companies (Acceptance of Deposits) Rules, 2014 during the year. There are no deposits which are outstanding as on 31st March, 2025. The Company has not accepted any deposits which are not in compliance with the requirements of Chapter V of the Companies Act, 2013.

33 Particulars of Loans, Guarantees or Investments (Under Section 186 of the Act):

Loans and Investments in compliance with the provisions of the Section 186 of the Companies Act, 2013 forms part of the Notes to the financial statements of the Company.

34 Risk Management Policy:

The Company has not formulated Risk Management Policy as it is not mandatory to the Company.

35 Corporate Social Responsibility Policy:

The Company is not covered under the requirements of Section 135 of the Act read with the Companies (Corporate Social Responsibility Policy) Rules 2014.

36 Related Party Transactions:

During the year under review, no transactions were entered into by the Company with its related parties as per the provisions of Section 188 of the Companies Act, 2013. Further, there were no contracts or arrangements with any related party which were material in nature, and hence the Form AOC-2 is not applicable to the Company.

The Policy on Materiality of Related Party Transactions and dealing with Related Party Transactions as approved by the Board is put up on the Companys website and can be accessed at https://docmode.org/policy/.

37 Disclosure on complaints received by the Internal Complaints Committee (ICC), formed under The Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013:

The Company has duly constituted an Internal Complaints Committee (ICC) in accordance with the provisions of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 but no complaints were received by the ICC during the year under review.

38 Disclosure relating to maintenance of cost records:

The Company is not required to conduct cost audit and maintenance of cost records is also not applicable to the company as per Section 148(1) of the Companies Act, 2013 and the rules made thereunder.

39 Details on Insolvency and Bankruptcy Code:

During the year under review, no application has been made by the Company under the Insolvency and Bankruptcy Code and accordingly the requirement of disclosing the following details is not applicable to the Company:

i. the details of application made or any proceeding pending under the Insolvency and Bankruptcy

Code, 2016 (31 of 2016) during the year along with their status as at the end of the financial year; and ii. the details of difference between amount of the valuation done at the time of onetime settlement and the valuation done while taking loan from the Banks or Financial Institutions along with the reasons thereof.

40 . Corporate Governance Report:

As company is listed on SME Exchange of NSE, the compliance with the corporate governance provisions as specified in LODR under regulations 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 and clauses (b) to (i) of sub-regulation (2) of regulation 46 and Para C, D and E of Schedule V are exempted to the company. Hence, requirements of corporate governance under regulation 27 and under Para C of Schedule V of LODR have not been included in this Annual Report.

41 . Details of utilization of funds & Statement of deviation(s) or variation(s):

Pursuant to Regulation 32(1) of the Listing Regulations, there was no deviation/variation in the utilization of proceeds raised in IPO by the Company. The NIL deviation reports, in respect of the IPO has been filed by the Company on a Half yearly basis, with NSE where equity shares of the Company are listed.

Further, the proceeds have been fully utilized for the purposes as disclosed in the offer document. Accordingly, no further disclosure under Regulation 32(2) is required to be given.

42. Compliance with the Maternity Benefit Act, 1961:

The Company has complied with the provisions of the Maternity Benefit Act, 1961, including all applicable amendments and rules framed thereunder. The Company is committed to ensuring a safe, inclusive, and supportive workplace for women employees. All eligible women employees are provided with maternity benefits as prescribed under the Maternity Benefit Act, 1961. The Company also ensures that no discrimination is made in recruitment or service conditions on the grounds of maternity. Necessary internal systems and HR policies are in place to uphold the spirit and letter of the legislation.

43. Acknowledgement:

The Directors express their sincere appreciation to the valued Stakeholders including Shareholders, Bankers and Clients for their support and contribution to the Company.

FOR AND ON BEHALF OF THE BOARD OF DIRECTORS
DOCMODE HEALTH TECHNOLOGIES LIMITED
PAULSON PAUL THAZHATHEDATH
CHAIRMAN AND WHOLE TIME DIRECTOR
DIN: 02301881
Place: Mumbai
Date: 29th August, 2025

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.